calendar
29,300 catalysts · 9,636 approval · 5,000 device 510k · 4,728 grant · 3,145 8k filing · 2,000 device pma · 2,000 device recall
29,300 catalysts · 9,636 approval · 5,000 device 510k · 4,728 grant · 3,145 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: JAZZ PHARMS THERAP. Form: POWDER. Route: INTRAVENOUS
Sponsor: BOEHRINGER INGELHEIM. Form: INJECTABLE. Route: INJECTION
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: CAPSULE. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: CAPSULE. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: LUPIN LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: RIGEL PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: TAIHO ONCOLOGY. Form: TABLET. Route: ORAL
Sponsor: DEXCEL PHARMA. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL